Abstract
The present application relates to activable inorganic nanoparticles which can be used in the health sector, in particular in human health, to disturb, alter or destroy target cancerous cells, tissues or organs. It more particularly relates to nanoparticles which can generate a surprisingly efficient therapeutic effect, when concentrated inside the tumor and exposed to ionizing radiations. The invention also relates to pharmaceutical compositions comprising a population of nanoparticles as defined previously, as well as to their uses.
Full Text
What is claimed is:
The present application relates to activable inorganic nanoparticles which can be used in the health sector, in particular in human health, to disturb, alter or destroy target cancerous cells, tissues or organs. It more particularly relates to nanoparticles which can generate a surprisingly efficient therapeutic effect, when concentrated inside the tumor and exposed to ionizing radiations. The invention also relates to pharmaceutical compositions comprising a population of nanoparticles as defined previously, as well as to their uses.
Timeline
Filed
06/12/2026Published
10/01/2026Granted
Not AvailableIPC Codes(4)
A61K 41/00:Medicinal preparations obtained by treating materials with wave energy or particle radiation
A61K 9/14:Particulate form, e.g. powders (microcapsules A61K 9/50)
A61N 5/10:X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy (takes precedence A61N 5/01)